CONCORD — The New Hampshire Department of Health and Human Services will hold a public information session next week on a proposed Alternative Treatment Center therapeutic cannabis dispensary in Chichester.
The planned Chichester ATC would be operated by Prime Alternative Treatment Centers of New Hampshire.
The Chichester center is one of two new centers authorized by the Legislature in 2019 and the proposed dispensary location was chosen to increase patient access to the state’s therapeutic cannabis program.
There are currently five Alternative Treatment Centers in New Hampshire, located in Conway, Dover, Merrimak, Lebanon and Plymouth. Patients who have qualifying medical conditions and have received a registry identification card from the state may select any of the ATCs but may select only one at any given time.
HB 335 allows for the establishment of two new therapeutic cannabis dispensaries in areas of the state where access to the currently established ATCs is limited. The new dispensaries are to be operated by Prime ATC in Region 2 (representing Hillsborough and Merrimack counties) and Temescal Wellness in Region 1 (representing Belknap, Rockingham, and Strafford counties).
Prime ATC currently operates its dispensary in Merrimack. As required by HB 335, DHHS conducted a patient needs assessment to determine locations that would have the greatest impact on patient access. The needs assessment identified the Concord area as a location that would best alleviate the travel burden on TCP patients in Region 2.
The public information session will be held at 6:30 p.m. on Tuesday, Jan. 5, via ZOOM, as part of the Chichester selectmen’s meeting.
Information on how to participate in the meeting remotely is posted on the town of Chichester’s website at tinyurl.com/y9n3z5wu.
During the public session, officials from the DHHS Therapeutic Cannabis Program and representatives from Prime ATC will make brief presentations and answer attendees’ questions.